Pipecuronium bromide is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It is grouped under the following drug class(es): Neuromuscular blocking agents. Its therapeutic use is listed as muscle relaxants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Arduan and Pipecurium bromide. Its PubChem CID is 65332.
Pipecuronium bromide
| CAS No | 52212-02-9 |
|---|---|
| Molecular Formula | C35H62Br2N4O4 |
| Molecular Weight | 762.7 g/mol |
| Synonyms | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pipecuronium bromide is a small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It is grouped under the following drug class(es): Neuromuscular blocking agents.
The listed CAS number is 52212-02-9.
The listed molecular formula is C35H62Br2N4O4.
The listed molecular weight is 762.7 g/mol.
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide.
The source lists Arduan and Pipecurium bromide.